comparemela.com

Page 9 - Daiichi Sankyo Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Daiichi Sankyo, Merck sign cancer therapy deal of up to $22 billion

Japanese pharmaceutical company Daiichi Sankyo Co. will receive payments totaling up to $22 billion from U.S. counterpart Merck & Co. in a tie-up deal covering the development and commercialization of three cancer therapies, the two firms say.

Merck To Pay as Much as $22 Billion for Daiichi Sankyo s Cancer Drugs

Merck To Pay as Much as $22 Billion for Daiichi Sankyo s Cancer Drugs
bloomberg.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bloomberg.com Daily Mail and Mail on Sunday newspapers.

Merck To Pay as Much as $22 Billion for Daiichi Cancer Drugs

Merck To Pay as Much as $22 Billion for Daiichi Cancer Drugs
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.